Improvement of insulin sensitivity by antagonism of the renin-angiotensin system (Q36854401)

16 August 2017

1 reference

title

Improvement of insulin sensitivity by antagonism of the renin-angiotensin system (English)

1 reference

16 August 2017

1 reference

Erik J Henriksen

1

1 reference

16 August 2017

publication date

20 June 2007

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

16 August 2017

published in

1 reference

16 August 2017

volume

293

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

R974-80

1 reference

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin I converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Introduction: organ involvement in the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin II enhances insulin sensitivity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Differential Gene Expression of Renin and Angiotensinogen in the TGR(mREN-2)27 Transgenic Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Voluntary exercise training enhances glucose transport but not insulin signaling capacity in muscle of hypertensive TG(mREN2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin II-induced insulin resistance and protein tyrosine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Activation of p70/p85 S6 kinase by a pathway independent of p21ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Role of insulin resistance in human disease (syndrome X): an expanded definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin II induces insulin resistance independent of changes in interstitial insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Exercise signalling to glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Impact of mutations at different serine residues on the tyrosine kinase activity of the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Insulin action and insulin resistance in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00147.2007

Effect of captopril, losartan, and bradykinin on early steps of insulin action

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIAB.46.12.1950

Identifiers

DOI

10.1152/AJPREGU.00147.2007

1 reference

release_dxaorireinfaleas7tqvsgdjqm

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dxaorireinfaleas7tqvsgdjqm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference